Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114740) titled 'Research on the Mechanism of Akkermansia muciniphila in Reducing Inflammation in Crohn's Disease' on Dec. 17, 2025.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital with Nanjing Medical University
Condition:
Inflammatory bowel disease
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Inflammatory bowel disease group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=297112
Published by HT Digital Content Services with permission from Health...